ARTICLE | Clinical News
Lapatinib regulatory update
March 1, 2010 8:00 AM UTC
The European Medicines Agency's CHMP issued a positive opinion to recommend expanding the indication of Tyverb lapatinib to include postmenopausal women with hormone receptor-positive metastatic breas...